These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
376 related articles for article (PubMed ID: 30561809)
21. Mobilization of hepatic mesenchymal stem cells from human liver grafts. Pan Q; Fouraschen SM; Kaya FS; Verstegen MM; Pescatori M; Stubbs AP; van Ijcken W; van der Sloot A; Smits R; Kwekkeboom J; Metselaar HJ; Kazemier G; de Jonge J; Tilanus HW; Wagemaker G; Janssen HL; van der Laan LJ Liver Transpl; 2011 May; 17(5):596-609. PubMed ID: 21506248 [TBL] [Abstract][Full Text] [Related]
22. An in Vitro and in Vivo Study of the Effect of Dexamethasone on Immunoinhibitory Function of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells. Wang D; Sun YQ; Gao WX; Fan XL; Shi JB; Fu QL Cell Transplant; 2018 Sep; 27(9):1340-1351. PubMed ID: 30056763 [TBL] [Abstract][Full Text] [Related]
23. Isolation and proliferation of umbilical cord tissue derived mesenchymal stem cells for clinical applications. Van Pham P; Truong NC; Le PT; Tran TD; Vu NB; Bui KH; Phan NK Cell Tissue Bank; 2016 Jun; 17(2):289-302. PubMed ID: 26679929 [TBL] [Abstract][Full Text] [Related]
24. A Comparative Study of the Therapeutic Potential of Mesenchymal Stem Cells and Limbal Epithelial Stem Cells for Ocular Surface Reconstruction. Holan V; Trosan P; Cejka C; Javorkova E; Zajicova A; Hermankova B; Chudickova M; Cejkova J Stem Cells Transl Med; 2015 Sep; 4(9):1052-63. PubMed ID: 26185258 [TBL] [Abstract][Full Text] [Related]
25. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies. Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828 [TBL] [Abstract][Full Text] [Related]
26. One-step Derivation of Functional Mesenchymal Stem Cells from Human Pluripotent Stem Cells. Zhou Y; Liao J; Fang C; Mo C; Zhou G; Luo Y Bio Protoc; 2018 Nov; 8(22):e3080. PubMed ID: 34532538 [TBL] [Abstract][Full Text] [Related]
27. Enrichment of human ESC-derived multipotent mesenchymal stem cells with immunosuppressive and anti-inflammatory properties capable to protect against experimental inflammatory bowel disease. Sánchez L; Gutierrez-Aranda I; Ligero G; Rubio R; Muñoz-López M; García-Pérez JL; Ramos V; Real PJ; Bueno C; Rodríguez R; Delgado M; Menendez P Stem Cells; 2011 Feb; 29(2):251-62. PubMed ID: 21732483 [TBL] [Abstract][Full Text] [Related]
28. Alternative Ways to Obtain Human Mesenchymal Stem Cells from Embryonic Stem Cells. Onyanov N; Glazova O; Sakr N; Krokunova T; Krupinova J; Volchkov P Cells; 2024 Sep; 13(19):. PubMed ID: 39404381 [TBL] [Abstract][Full Text] [Related]
29. Human placental stem cells: biomedical potential and clinical relevance. Malek A; Bersinger NA J Stem Cells; 2011; 6(2):75-92. PubMed ID: 22997848 [TBL] [Abstract][Full Text] [Related]
30. Methods to produce induced pluripotent stem cell-derived mesenchymal stem cells: Mesenchymal stem cells from induced pluripotent stem cells. Dupuis V; Oltra E World J Stem Cells; 2021 Aug; 13(8):1094-1111. PubMed ID: 34567428 [TBL] [Abstract][Full Text] [Related]
34. Human Wharton's jelly mesenchymal stem cells maintain the expression of key immunomodulatory molecules when subjected to osteogenic, adipogenic and chondrogenic differentiation in vitro: new perspectives for cellular therapy. La Rocca G; Lo Iacono M; Corsello T; Corrao S; Farina F; Anzalone R Curr Stem Cell Res Ther; 2013 Jan; 8(1):100-13. PubMed ID: 23317435 [TBL] [Abstract][Full Text] [Related]
35. Chemically Defined Conditions Mediate an Efficient Induction of Mesodermal Lineage from Human Umbilical Cord- and Bone Marrow- Mesenchymal Stem Cells and Dental Pulp Pluripotent-Like Stem Cells. Al Madhoun A; Alkandari S; Ali H; Carrio N; Atari M; Bitar MS; Al-Mulla F Cell Reprogram; 2018 Feb; 20(1):9-16. PubMed ID: 29412734 [TBL] [Abstract][Full Text] [Related]
36. Concise Review: Quantitative Detection and Modeling the In Vivo Kinetics of Therapeutic Mesenchymal Stem/Stromal Cells. Brooks A; Futrega K; Liang X; Hu X; Liu X; Crawford DHG; Doran MR; Roberts MS; Wang H Stem Cells Transl Med; 2018 Jan; 7(1):78-86. PubMed ID: 29210198 [TBL] [Abstract][Full Text] [Related]
37. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells. Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235 [TBL] [Abstract][Full Text] [Related]
38. Identifying the Therapeutic Significance of Mesenchymal Stem Cells. Mishra VK; Shih HH; Parveen F; Lenzen D; Ito E; Chan TF; Ke LY Cells; 2020 May; 9(5):. PubMed ID: 32384763 [TBL] [Abstract][Full Text] [Related]
39. Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress. Wu X; Jiang J; Gu Z; Zhang J; Chen Y; Liu X Stem Cell Res Ther; 2020 Aug; 11(1):345. PubMed ID: 32771052 [TBL] [Abstract][Full Text] [Related]